The field of oncology is so broad, and theres so much to be done, Kummar says. Learn more about clinical trials at the Knight Cancer Institute, The 13,000-square-foot early-phase research unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. 23() 'Oregon Health & Science University Knight Cancer Institute(OHSU)' BAL0891 1 Shivaani Kummar (Principal Investigator, PI), OHSU 'Mary Crowley Cancer Research . She runs early phase clinical trials evaluating new treatments while ensuring highest standards of patient safety. The Knight Cancer Institute's Center for Experimental Therapeutics (CET) represents multidisciplinary collaborations among scientists, physicians and engineers across OHSU. In her most recent role at Stanford University, Kummar held a number of titles, including: professor of medicine and radiology; associate division chief for academic affairs; director, phase I clinical research program; and co-director of the Translational Oncology Program. Vol.49 No.07. Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid condition, procedure, doctor name. Education & Training Oregon Health & Science University Fellowship, Hematology and Medical Oncology, 1995 - 1997 New York Presbyterian Hospital (Columbia Campus) Residency, Internal Medicine, 1990 - 1993 Harvard Medical School Class of 1989 OHSU is an equal opportunity affirmative action institution. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. You may also qualify for Phase 1 Program trials. Patients and Methods. (OHSU/Joe Rojas-Burke), Shivaani Kummar, M.D., FACP, head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's Center for Experimental Therapeutics, talks with OHSU Knight Cancer Institute Director Brian Druker, M.D., at the opening of OHSU's early-phase clinical trial unit in the Center for Health and Healing Building 2 on OHSU's South Waterfront campus, Aug. 23, 2021. We are thrilled he is able to co-lead this new venture. OHSU HOSPITAL AND CLINICS: 380009: Provider Business Practice Location Address Details: Address: 3181 Sw Sam Jackson Park Rd, City: Portland . Increasing patient participation in oncology clinical trials, A Novel Artificial IntelligencePowered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers, Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas, Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer. Dr. Shivaani Kummar, Oncologist - FindaTopDoc Having someone who understands the challenges is helpful.. The 13,000-square-foot early-phase research unit is located on the 12th floor of OHSUs Center for Health and Healing Building 2 on OHSUs South Waterfront campus. Dr. Shivaani Kummar is an oncologist practicing in Bethesda, MD. 1. cleveland, tx funeral homes share dancing on ice app for ipad tweet exhaustive list of cushing's syndrome symptoms share. Recent external collaboration on country/territory level. Get to know some of the resear. boundtree continuing education; can you be charged under ucmj after discharge Each faculty member comes with a unique background, which often propels him or her into medicine and a particular . In 2014, the state of Oregon supported the OHSU Knight Cancer Challenge by providing $200 million in bonding to support building cancer research and clinical trial capacity. Due to Covid-19 pandemic, the 2020 Symposium was postponed to 2021. OHSU expands capacity for cancer clinical trials | OHSU News OHSU HOSPITAL AND CLINICS - (Acute Care) 3181 SW SAM JACKSON PARK ROAD Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. Before scheduling your appointment, we recommend you contact yourinsurancecompany to verify that the OHSU Health location or provider you plan to visit is included in your network. We are delighted she has chosen to join us, said Brian Druker, M.D., director of the OHSU Knight Cancer Institute. Keep me signed in. Notice of Privacy Practices Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. The new unit centralizes care for patients in research studies and expands capacity to allow more people to participate in early-phase clinical trials at OHSU. A Rajan, CA Carter, RJ Kelly, M Gutierrez, S Kummar, E Szabo, Clinical cancer research 18 (8), 2344-2351. Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. We also share information about your use of our site with our trusted social media, advertising and analytics partners. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. A Novel Artificial Intelligence-Powered Method for Prediction of Early SHIVAANI KUMMAR, Medical Oncology PORTLAND, OR - NPI 1053612341 Administrative Coordinator, Karri Garaventa To find better ways to treat patients. 2001-2022 Oregon Health & Science University. 2001-2023 OHSU. Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU Together their goal is to find a cure for cancer. Ashok Muralidaran, M.D., discusses how his passions inspire his work as a pediatric cardiac surgeon. Notice of Privacy Practices Updated health-related quality of life of patients with TRK-fusion cancer treated with larotrectinib in clinical trials. 1 - 20 out of 67 Results for "Shivaani Kummar" 67 Results Select All . Caring for them drives me to work harder to develop more effective treatments that are better tolerated. Dr. Kummar joined the OHSU Knight Cancer Institute from Stanford University in July 2020. By continuing you agree to the use of cookies. shivaani kummar ohsu email. Each study answers scientific questions and tries to find better ways to prevent, diagnose or treat diseases like cancer. Shivaani Kummar. What are the latest results? Increasing (gender) diversity on a journal: a case study - Elsevier Connect This center will be for the community, and we hope people will reach out to be a part of it. shivaani kummar ohsu email - howfenalcooksthat.com Local: (503) 228-1730 | Toll Free: (800) 462-6608 Cited by. Office 3181 SW Sam Jackson Park Rd Portland, OR 97239 Phone+1 503-280-1223 Is this information wrong? , 'Bal0891' 1 < < < - Overall: 4.7 out of 5 DS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, S Kummar, R Kinders, ME Gutierrez, L Rubinstein, RE Parchment, Journal of clinical oncology 27 (16), 2705. These new agents include those targeting genetic changes (alterations in the DNA of the cancer cell), those that harness the immune system to work against the cancer, and others. OHSU is an equal opportunity affirmative action institution. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. These topic labels come from the works of this person. These new drugs go through very rigorous testing in the laboratory and only if they meet certain criteria as promising anticancer agents, we bring them forward into the first phase of human clinical trials. Yourinsurancecompany will also be able to inform you of any copayments, coinsurance, or deductibles that will be your responsibility. General Information Email: ohsufinfo@ohsu.edu, Mailing Address Cited by. Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Sign up to receive the latest news, updates and stories from the OHSU Foundation in your inbox. S Kummar, A Chen, J Ji, Y Zhang, JM Reid, M Ames, L Jia, M Weil, K Do, D Wilsker, J Ji, J Zlott, T Freshwater, RJ Kinders, J Collins, AP Chen, Journal of Clinical Oncology 33 (30), 3409. Together they have built a strong record of discovery, innovation and care. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Clinical trials are research studies that test how well new medicines or treatments work in people. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. This symposium is intended to be an annual event that rotates its location between Stanford University, the University of Chicago, the University of Connecticut and the Oregon Health Science University. Affiliated Hospitals Medical Group Practices Practice Location 3181 Sw Sam Jackson Park Rd Portland, Oregon 97239-3011 Map and Directions Phone: (503) 314-7168 Office Hours: Monday - Friday: 8:00 AM - 5:00 PM Saturday - Sunday: Closed 23 () 'Oregon Health & Science University Knight Cancer Institute (OHSU)' BAL0891 1 . . Stat4Onc Annual Symposium A husband-wife team known for specializing in cancer drug development have joined the OHSU Knight Cancer Institute. Notice of Privacy Practices Dive into details by clicking on the dots or, Knight Cancer Translational Oncology Program, Calculated based on number of publications stored in Pure and citations from Scopus, PQ3: Age-related immune deviation and cancer outcome, [18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors, Understanding the origins of rapid recurrence of pancreatic cancer after resection. OHSU is an equal opportunity affirmative action institution. Over the past six months, a multidisciplinary team has been coordinating patient experience, drug delivery, staffing schedules and equipment needed to support the range of clinical trials offered in the unit that span 14 different cancer disease groups. Within our Center for Experimental Therapeutics, Knight Cancer Institute, we have multiple ongoing projects trying to identify new ways to target cancer. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. A Ribas, T Medina, S Kummar, A Amin, A Kalbasi, JJ Drabick, M Barve, S Kummar, D Allen, A Monks, EC Polley, CD Hose, SP Ivy, IB Turkbey, Journal of Clinical Oncology 31 (18), 2296, Critical reviews in oncology/hematology 53 (3), 199-207, S Kummar, M Gutierrez, JH Doroshow, AJ Murgo, British journal of clinical pharmacology 62 (1), 15-26. Want to join the faculty at the Knight Cancer Institute? Visit thebilling andinsurancesection of our sitefor more information. Claire Yoshida, M.S.N., A.C.N.S.-B.C., A.C.H.P.N. Share on email. Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute, speaks with staff members on Aug. 23, 2021. Shivaani Kummar Stanford University Medical Center - PMWC Precision Medicine World Conference Speaker Profile M.D., Professor of Medicine and Radiology, Stanford University; Director, Phase I Clinical Research Program-Medical Oncology; Director, Translational Oncology Program At Stanford Shivaani Kummar Biography Of that, $160 million was used for the Knight Cancer Research Building, which opened in 2018, and $40 million was used to build expanded capacity for clinical trial care in CHH2, which opened in 2019. You can also correspond with Dr. Shivaani Kummar through mail at her mailing address at 3181 Sw Sam Jackson Park Rd, , Portland, Oregon - 97239-3011 (mailing address contact number - 503-314-7168). Primary Care Physicians Browse Primary Care Physiciansnear you Atlanta, GA Austin, TX Baltimore, MD Boston, MA Chicago, IL Dallas, TX Denver, CO Detroit, MI Houston, TX Sanjay Malhotra, Ph.D. Shivaani Kummar, M.D., FACP Our ability to move these projects forward and to take on new projects is limited by the available resources. Our ability to collaborate with academics and industries across the globe will be paramount to our success in developing new drugs for patients. Administrative Coordinator, Denise Hopkins Dr. Shivaani Kummar, MD is a medical oncology specialist in Portland, OR. , 1 shivaani kummar ohsu email Year; Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. Shivaani Kummar is a Hematology & Medical Oncology Head at Oregon Health & Science University based in Portland, Oregon. Leadership The Center for Experimental Therapeutics is co-led by Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D. edu h-index 8546 Citations 49 h-index 1996 2023 Research activity per year Overview Fingerprint Network Grants (5) Publications (174) Similar Profiles (1) If you made any changes in Pure these will be visible here soon. Entp Childhood Trauma, Baby Shower Venues Santa Clarita, Ca, What To Do With Expired Cake Mix, What Institutions Of Justice Are Necessary For Integral Human Flourishing?, Articles S
">
+43 650 4114540
relationship and biodiversity lab

shivaani kummar ohsu email

shivaani kummar ohsu email

bard college music faculty. . Try restaurant style recipes at home. Dr. Shivaani Kummar is an oncologist in Palo Alto, California and is affiliated with OHSU Hospital. Shivaani Kummar Dr. Kummar was recently appointed as Division Chief of Hematology and Oncology, and co-Director of the Center for Experimental Therapeutics, at the Oregon Health and Science University in Portland, Oregon. The field of oncology is so broad, and theres so much to be done, Kummar says. Learn more about clinical trials at the Knight Cancer Institute, The 13,000-square-foot early-phase research unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. 23() 'Oregon Health & Science University Knight Cancer Institute(OHSU)' BAL0891 1 Shivaani Kummar (Principal Investigator, PI), OHSU 'Mary Crowley Cancer Research . She runs early phase clinical trials evaluating new treatments while ensuring highest standards of patient safety. The Knight Cancer Institute's Center for Experimental Therapeutics (CET) represents multidisciplinary collaborations among scientists, physicians and engineers across OHSU. In her most recent role at Stanford University, Kummar held a number of titles, including: professor of medicine and radiology; associate division chief for academic affairs; director, phase I clinical research program; and co-director of the Translational Oncology Program. Vol.49 No.07. Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid condition, procedure, doctor name. Education & Training Oregon Health & Science University Fellowship, Hematology and Medical Oncology, 1995 - 1997 New York Presbyterian Hospital (Columbia Campus) Residency, Internal Medicine, 1990 - 1993 Harvard Medical School Class of 1989 OHSU is an equal opportunity affirmative action institution. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. You may also qualify for Phase 1 Program trials. Patients and Methods. (OHSU/Joe Rojas-Burke), Shivaani Kummar, M.D., FACP, head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's Center for Experimental Therapeutics, talks with OHSU Knight Cancer Institute Director Brian Druker, M.D., at the opening of OHSU's early-phase clinical trial unit in the Center for Health and Healing Building 2 on OHSU's South Waterfront campus, Aug. 23, 2021. We are thrilled he is able to co-lead this new venture. OHSU HOSPITAL AND CLINICS: 380009: Provider Business Practice Location Address Details: Address: 3181 Sw Sam Jackson Park Rd, City: Portland . Increasing patient participation in oncology clinical trials, A Novel Artificial IntelligencePowered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers, Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas, Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer. Dr. Shivaani Kummar, Oncologist - FindaTopDoc Having someone who understands the challenges is helpful.. The 13,000-square-foot early-phase research unit is located on the 12th floor of OHSUs Center for Health and Healing Building 2 on OHSUs South Waterfront campus. Dr. Shivaani Kummar is an oncologist practicing in Bethesda, MD. 1. cleveland, tx funeral homes share dancing on ice app for ipad tweet exhaustive list of cushing's syndrome symptoms share. Recent external collaboration on country/territory level. Get to know some of the resear. boundtree continuing education; can you be charged under ucmj after discharge Each faculty member comes with a unique background, which often propels him or her into medicine and a particular . In 2014, the state of Oregon supported the OHSU Knight Cancer Challenge by providing $200 million in bonding to support building cancer research and clinical trial capacity. Due to Covid-19 pandemic, the 2020 Symposium was postponed to 2021. OHSU expands capacity for cancer clinical trials | OHSU News OHSU HOSPITAL AND CLINICS - (Acute Care) 3181 SW SAM JACKSON PARK ROAD Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. Before scheduling your appointment, we recommend you contact yourinsurancecompany to verify that the OHSU Health location or provider you plan to visit is included in your network. We are delighted she has chosen to join us, said Brian Druker, M.D., director of the OHSU Knight Cancer Institute. Keep me signed in. Notice of Privacy Practices Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. The new unit centralizes care for patients in research studies and expands capacity to allow more people to participate in early-phase clinical trials at OHSU. A Rajan, CA Carter, RJ Kelly, M Gutierrez, S Kummar, E Szabo, Clinical cancer research 18 (8), 2344-2351. Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. We also share information about your use of our site with our trusted social media, advertising and analytics partners. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. A Novel Artificial Intelligence-Powered Method for Prediction of Early SHIVAANI KUMMAR, Medical Oncology PORTLAND, OR - NPI 1053612341 Administrative Coordinator, Karri Garaventa To find better ways to treat patients. 2001-2022 Oregon Health & Science University. 2001-2023 OHSU. Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU Together their goal is to find a cure for cancer. Ashok Muralidaran, M.D., discusses how his passions inspire his work as a pediatric cardiac surgeon. Notice of Privacy Practices Updated health-related quality of life of patients with TRK-fusion cancer treated with larotrectinib in clinical trials. 1 - 20 out of 67 Results for "Shivaani Kummar" 67 Results Select All . Caring for them drives me to work harder to develop more effective treatments that are better tolerated. Dr. Kummar joined the OHSU Knight Cancer Institute from Stanford University in July 2020. By continuing you agree to the use of cookies. shivaani kummar ohsu email. Each study answers scientific questions and tries to find better ways to prevent, diagnose or treat diseases like cancer. Shivaani Kummar. What are the latest results? Increasing (gender) diversity on a journal: a case study - Elsevier Connect This center will be for the community, and we hope people will reach out to be a part of it. shivaani kummar ohsu email - howfenalcooksthat.com Local: (503) 228-1730 | Toll Free: (800) 462-6608 Cited by. Office 3181 SW Sam Jackson Park Rd Portland, OR 97239 Phone+1 503-280-1223 Is this information wrong? , 'Bal0891' 1 < < < - Overall: 4.7 out of 5 DS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, S Kummar, R Kinders, ME Gutierrez, L Rubinstein, RE Parchment, Journal of clinical oncology 27 (16), 2705. These new agents include those targeting genetic changes (alterations in the DNA of the cancer cell), those that harness the immune system to work against the cancer, and others. OHSU is an equal opportunity affirmative action institution. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. These topic labels come from the works of this person. These new drugs go through very rigorous testing in the laboratory and only if they meet certain criteria as promising anticancer agents, we bring them forward into the first phase of human clinical trials. Yourinsurancecompany will also be able to inform you of any copayments, coinsurance, or deductibles that will be your responsibility. General Information Email: ohsufinfo@ohsu.edu, Mailing Address Cited by. Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Sign up to receive the latest news, updates and stories from the OHSU Foundation in your inbox. S Kummar, A Chen, J Ji, Y Zhang, JM Reid, M Ames, L Jia, M Weil, K Do, D Wilsker, J Ji, J Zlott, T Freshwater, RJ Kinders, J Collins, AP Chen, Journal of Clinical Oncology 33 (30), 3409. Together they have built a strong record of discovery, innovation and care. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Clinical trials are research studies that test how well new medicines or treatments work in people. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. This symposium is intended to be an annual event that rotates its location between Stanford University, the University of Chicago, the University of Connecticut and the Oregon Health Science University. Affiliated Hospitals Medical Group Practices Practice Location 3181 Sw Sam Jackson Park Rd Portland, Oregon 97239-3011 Map and Directions Phone: (503) 314-7168 Office Hours: Monday - Friday: 8:00 AM - 5:00 PM Saturday - Sunday: Closed 23 () 'Oregon Health & Science University Knight Cancer Institute (OHSU)' BAL0891 1 . . Stat4Onc Annual Symposium A husband-wife team known for specializing in cancer drug development have joined the OHSU Knight Cancer Institute. Notice of Privacy Practices Dive into details by clicking on the dots or, Knight Cancer Translational Oncology Program, Calculated based on number of publications stored in Pure and citations from Scopus, PQ3: Age-related immune deviation and cancer outcome, [18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors, Understanding the origins of rapid recurrence of pancreatic cancer after resection. OHSU is an equal opportunity affirmative action institution. Over the past six months, a multidisciplinary team has been coordinating patient experience, drug delivery, staffing schedules and equipment needed to support the range of clinical trials offered in the unit that span 14 different cancer disease groups. Within our Center for Experimental Therapeutics, Knight Cancer Institute, we have multiple ongoing projects trying to identify new ways to target cancer. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. A Ribas, T Medina, S Kummar, A Amin, A Kalbasi, JJ Drabick, M Barve, S Kummar, D Allen, A Monks, EC Polley, CD Hose, SP Ivy, IB Turkbey, Journal of Clinical Oncology 31 (18), 2296, Critical reviews in oncology/hematology 53 (3), 199-207, S Kummar, M Gutierrez, JH Doroshow, AJ Murgo, British journal of clinical pharmacology 62 (1), 15-26. Want to join the faculty at the Knight Cancer Institute? Visit thebilling andinsurancesection of our sitefor more information. Claire Yoshida, M.S.N., A.C.N.S.-B.C., A.C.H.P.N. Share on email. Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute, speaks with staff members on Aug. 23, 2021. Shivaani Kummar Stanford University Medical Center - PMWC Precision Medicine World Conference Speaker Profile M.D., Professor of Medicine and Radiology, Stanford University; Director, Phase I Clinical Research Program-Medical Oncology; Director, Translational Oncology Program At Stanford Shivaani Kummar Biography Of that, $160 million was used for the Knight Cancer Research Building, which opened in 2018, and $40 million was used to build expanded capacity for clinical trial care in CHH2, which opened in 2019. You can also correspond with Dr. Shivaani Kummar through mail at her mailing address at 3181 Sw Sam Jackson Park Rd, , Portland, Oregon - 97239-3011 (mailing address contact number - 503-314-7168). Primary Care Physicians Browse Primary Care Physiciansnear you Atlanta, GA Austin, TX Baltimore, MD Boston, MA Chicago, IL Dallas, TX Denver, CO Detroit, MI Houston, TX Sanjay Malhotra, Ph.D. Shivaani Kummar, M.D., FACP Our ability to move these projects forward and to take on new projects is limited by the available resources. Our ability to collaborate with academics and industries across the globe will be paramount to our success in developing new drugs for patients. Administrative Coordinator, Denise Hopkins Dr. Shivaani Kummar, MD is a medical oncology specialist in Portland, OR. , 1 shivaani kummar ohsu email Year; Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. Shivaani Kummar is a Hematology & Medical Oncology Head at Oregon Health & Science University based in Portland, Oregon. Leadership The Center for Experimental Therapeutics is co-led by Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D. edu h-index 8546 Citations 49 h-index 1996 2023 Research activity per year Overview Fingerprint Network Grants (5) Publications (174) Similar Profiles (1) If you made any changes in Pure these will be visible here soon.

Entp Childhood Trauma, Baby Shower Venues Santa Clarita, Ca, What To Do With Expired Cake Mix, What Institutions Of Justice Are Necessary For Integral Human Flourishing?, Articles S